“. . . the School could choose to move toward a leadership role in the nursing profession, committing its sizable faculty resources to pushing back the frontiers of knowledge in the art and science of helping people care for their health and overcome illness. The School could choose to firmly establish itself as a leader […]

UConn scientists are working with a biomarker to enable earlier detection of a condition that leads to age-related macular degeneration, the leading cause of blindness in the U.S.

A beloved accounting professor who never regretted trading in the bustle of New York City for the tranquility of Storrs, will be honored through a new scholarship that bears his name.

UConn biomedical engineering researchers are developing new heart monitors to improve early detection of an irregular heartbeat.

Advanced lung cancer patient Michel Gueret had a life expectancy of less than a year at the time of diagnosis. After participating in an immunotherapy clinical trial at UConn Health, he now has no more lung cancer symptoms.